Ethics and technology hold the key to the success of synthetic biology
Targeted cancer treatments, toxicity sensors and living factories: synthetic biology has the potential to revolutionize science and medicine. But before the technology is ready for real-world applications, more attention needs to be paid to its safety and stability, say experts in a review article published in Current Opinion in Chemical Biology.
Synthetic biology involves engineering microbes like bacteria to program them to behave in certain ways. For example, bacteria can be engineered to glow when they detect certain molecules, and can be turned into tiny factories to produce chemicals.
Synthetic biology has now reached a stage where it’s ready to move out of the lab and into the real world, to be used in patients and in the field. According to Professor Pamela Silver, one of the authors of the article from Harvard Medical School in the US, this move means researchers should increase focus on the safety of engineered microbes in biological systems like the human body.
“Historically, molecular biologists engineered microbes as industrial organisms to produce different molecules,” said Professor Silver. “The more we discovered about microbes, the easier it was to program them. We’ve now reached a very exciting phase in synthetic biology where we’re ready to apply what we’ve developed in the real world, and this is where safety is vital.”
Microbes have an impact on health; the way they interact with animals is being ever more revealed by microbiome research – studies on all the microbes that live in the body – and this is making them easier and faster to engineer. Scientists are now able to synthesize whole genomes, making it technically possible to build a microbe from scratch.
“Ultimately, this is the future – this will be the way we program microbes and other cell types,” said Dr. Silver. “Microbes have small genomes, so they’re not too complex to build from scratch. That gives us huge opportunities to design them to do specific jobs, and we can also program in safety mechanisms.”
One of the big safety issues associated with engineering microbial genomes is the transfer of their genes to wild microbes. Microbes are able to transfer segments of their DNA during reproduction, which leads to genetic evolution. One key challenge associated with synthetic biology is preventing this transfer between the engineered genome and wild microbial genomes.
There are already several levels of safety infrastructure in place to ensure no unethical research is done, and the kinds of organisms that are allowed in laboratories. The focus now, according to Dr. Silver, is on technology to ensure safety. When scientists build synthetic microbes, they can program in mechanisms called kill switches that cause the microbes to self-destruct if their environment changes in certain ways.
Microbial sensors and drug delivery systems can be shown to work in the lab, but researchers are not yet sure how they will function in a human body or a large-scale bioreactor. Engineered organisms have huge potential, but they will only be useful if proven to be reliable, predictable, and cost effective. Today, engineered bacteria are already in clinical trials for cancer, and this is just the beginning, says Dr. Silver.
“The rate at which this field is moving forward is incredible. I don’t know what happened – maybe it’s the media coverage, maybe the charisma – but we’re on the verge of something very exciting. Once we’ve figured out how to make genomes more quickly and easily, synthetic biology will change the way we work as researchers, and even the way we treat diseases.”
The Latest on: Synthetic biology
via Google News
The Latest on: Synthetic biology
- Kraig Biocraft Laboratories CEO to Present at SynBio Markets 2020on April 6, 2020 at 4:59 am
SynBio Markets focus is synthetic biology solutions to commercial and sustainability challenges. The international conference is designed to showcase the most innovative synthetic biology companies.
- Molecular Biology Enzymes, Kits, & Reagents Market Overview By Share, Size, Industry Players, Revenue And Product Demand Forecast Till 2029on April 3, 2020 at 2:34 am
Global Molecular Biology Enzymes, Kits, & Reagents market is expected to foster due to increasing research and ...
- A primer on emerging field-deployable synthetic biology tools for global water quality monitoringon April 3, 2020 at 2:06 am
Tracking progress towards Target 6.1 of the United Nations Sustainable Development Goals, “achieving universal and equitable access to safe and affordable drinking water for all”, necessitates the ...
- Zhen Wangon April 2, 2020 at 11:15 am
Zhen Wang is an expert on medicinal plants and synthetic biology. She can discuss the history of plant-derived medicines, and efforts to effectively produce such drugs for modern health care systems.
- Turning cells into computers with protein logic gateson April 2, 2020 at 11:01 am
The advances have implications for future medicines and synthetic biology. Reporting April 2 in the journal Science, a team led by the University of Washington School of Medicine has created ...
- The next trillion+ dollar industryon April 2, 2020 at 9:20 am
Deep focuses on fields such as frontier tech, genomics technologies and synthetic biology - and has invested in some market leaders including Zymergen, Slack and Collective Health. It was a pleasure ...
- Photosynthetic proteins developed for expanded solar energy conversionon April 1, 2020 at 7:26 am
The initiative is part of a broader effort in the field of synthetic biology to use proteins in place of man-made materials which are often scarce, expensive and can be harmful to the environment when ...
- Global Synthetic Biology Market Research Report | Thermo Fisher Scientific, Algenol Biofuels Inc and Amyris Incon March 27, 2020 at 12:05 am
Global Synthetic Biology Market (Revenue and Volume), Type, Application, End-User, and Regional Analysis, Import-Export Analysis, Industry Analysis, Premium Insights, Intellectual Property Analysis, ...
- Synthetic Biology Market To Reach USD 20.64 Billion By 2027 | Thermo Fisher, Merck KGaA, Novozymes, DNA2.0, Eurofins Scientific, Inc., Intrexonon March 26, 2020 at 5:15 am
The Global Synthetic Biology Market is estimated to reach USD 20.64 Billion by 2027, according to a new report by Reports and Data. This can be mainly associated with the rising need to know the ...
- Twist Bioscience Synthetic SARS-CoV-2 RNA Controls Added to FDA Website as Reference Materialson March 25, 2020 at 5:00 am
About Twist Bioscience Corporation Twist Bioscience is a leading and rapidly growing synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering ...
via Bing News